E-ISSN 2149-388X | ISSN 2149-0430
 
2023, Vol: 9, Issue: 3
9 / 3Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Original Research 


Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole.

Abstract
Introduction: Diabetes increases the risk of developing neuropathy. In this study, we estimate the effect of Metformin, rosiglitazone, and pioglitazone on the body weight, blood glucose and creatinine level of alloxan-induced diabetic rats.
Materials and Method: Alloxan (150 mg/kg) was used to induce hyperglycemia in fasted rats. Hyperglycaemia was treated with metformin, 150 mg/kg/d; pioglitazone, 3 mg/kg/d; and rosiglitazone, 10 mg/kg/d). The anti-diabetic drugs were administered orally for 28 days. The kidneys were removed when the animals were sacrificed plasma and kidney creatinine level was measured.
Results: There was the reduction in weight of diabetic rats and those administered with metformin while there was an increase in weight of rats administered with rosiglitazone and pioglitazone. There is also reduction in blood glucose level of all treated rats compared with the diabetes control. The effects of creatinine on muscle metabolism generation and serum are insignificant at P≤0.05.
Conclusion: This experiment suggests that short-term diabetes does not have an effect on plasma creatinine level and muscle metabolism of alloxan-induced diabetic rats.

Key words: Plasma glucose, Creatinine, Metformin, Thiazolidinediones


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ojo Patience Oluwatomilayo
Articles by Akinola Busayo Oluwole
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. Ulutas Med J. 2018; 4(2): 73-77. doi:10.5455/umj.20180116075446

Web Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. https://www.ulutasmedicaljournal.com/?mno=288358 [Access: September 29, 2023]. doi:10.5455/umj.20180116075446

AMA (American Medical Association) Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. Ulutas Med J. 2018; 4(2): 73-77. doi:10.5455/umj.20180116075446


Vancouver/ICMJE Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. Ulutas Med J. (2018), [cited September 29, 2023]; 4(2): 73-77. doi:10.5455/umj.20180116075446


Harvard Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole (2018) Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. Ulutas Med J, 4 (2), 73-77. doi:10.5455/umj.20180116075446


Turabian Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. 2018. Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. THE ULUTAS MEDICAL JOURNAL, 4 (2), 73-77. doi:10.5455/umj.20180116075446


Chicago Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. "Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones." THE ULUTAS MEDICAL JOURNAL 4 (2018), 73-77. doi:10.5455/umj.20180116075446


MLA (The Modern Language Association) Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole. "Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones." THE ULUTAS MEDICAL JOURNAL 4.2 (2018), 73-77. Print. doi:10.5455/umj.20180116075446


APA (American Psychological Association) Style

Ojo Patience Oluwatomilayo, Akinola Busayo Oluwole (2018) Estimation of Plasma Glucose and Creatinine Level in Alloxan-induced Diabetic Wistar Rats treated with Metformin and Thiazolidinediones. THE ULUTAS MEDICAL JOURNAL, 4 (2), 73-77. doi:10.5455/umj.20180116075446


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writin ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.